Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-17-000035

Options or other derivatives

  • CEO / President acquired 21,336 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K. · CEO / President

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-15 Grant or award : show line 1 in the form Options to buy Common Stock +21,336 $0.29 $6,187 21,336 D
Loading xslF345X03/primary_doc.xml…